All vaccines

• BCG BCG (tuberculosis) vaccine

  BCG (tuberculosis) vaccine side effects, efficacy, and international schedule data. Not part of the routine U.S. childhood schedule — this page covers who gets it, why, and what the evidence shows.

  Platform not recordedOtherNot recorded

• Cholera Cholera Vaccine

  Single-dose oral option (Vaxchora) for U.S. travelers; killed whole-cell vaccines for outbreak response.

  Platform not recordedTravel

• COVID-19 COVID-19 Vaccine

  Largest safety database in history (675M+ U.S. doses). Myocarditis signal in adolescent males.

  Platform not recordedRoutineAll ages

• DTaP / Tdap Diphtheria, Tetanus & Pertussis Vaccine

  5-dose infant DTaP series + adolescent Tdap booster. Maternal Tdap during pregnancy.

  Platform not recordedRoutineInfant & childAdult

• Hepatitis A Hepatitis A Vaccine

  Inactivated whole-virus vaccine. 2-dose series starting at 12 months. One of the least reactogenic vaccines.

  InactivatedRoutineInfant & child

• Hepatitis B Hepatitis B Vaccine

  Recombinant vaccine. 3-dose series starting at birth.

  Recombinant / subunitRoutineInfant & child

• Hib Haemophilus influenzae type b Vaccine

  Conjugate vaccine. 2–3 dose primary series + booster. >99% reduction in invasive Hib disease.

  ConjugateRoutineInfant & child

• HPV Human Papillomavirus Vaccine

  Virus-like particle vaccine. 2 or 3 doses ages 9+. First anti-cancer vaccine.

  Platform not recordedRoutineAdolescent

• Influenza Influenza Vaccine

  Reformulated annually. IIV (injection) and LAIV (intranasal). Variable effectiveness (10–60%).

  Platform not recordedRoutineAll ages

• Japanese Encephalitis Japanese Encephalitis Vaccine

  Inactivated, Vero cell-derived. For travelers to rural Asia-Pacific during transmission season.

  InactivatedTravel

• Meningococcal Meningococcal Conjugate Vaccine

  MenACWY (2 doses, universal) + MenB (shared decision-making). Licensed via immunogenicity, not clinical efficacy.

  Platform not recordedRoutineAdolescent

• MMR Measles, Mumps & Rubella

  Live attenuated vaccine. Two-dose series at 12–15 months and 4–6 years.

  Live attenuatedRoutineInfant & child

• PCV (Pneumococcal) Pneumococcal Conjugate Vaccine

  4-dose series. PCV7 pivotal trial (N=38,000) was one of the largest pediatric vaccine trials.

  Platform not recordedRoutineInfant & child

• Polio (IPV) Inactivated Poliovirus Vaccine

  4-dose series. U.S. switched from OPV to IPV in 2000 to eliminate vaccine-associated paralytic polio risk.

  Platform not recordedRoutineInfant & child

• Rabies Rabies Vaccine

  Pre-exposure for travelers/animal handlers; post-exposure prophylaxis essentially 100% effective.

  Platform not recordedTravel

• Rotavirus Rotavirus Vaccine

  Live attenuated oral vaccine. 2–3 dose series. Small intussusception risk identified post-licensure.

  Live attenuatedRoutineInfant & child

• RSV Respiratory Syncytial Virus Preventive

  2023–2024 preventives: Arexvy, Abrysvo (maternal), Beyfortus (infant mAb).

  Platform not recordedRoutineInfant & childAdult

• Shingles Shingles (Herpes Zoster) Vaccine

  Recombinant zoster vaccine (Shingrix). 2-dose series for adults ≥50.

  Recombinant / subunitAdult

• Typhoid Typhoid Fever Vaccine

  Injectable (ViCPS) or oral (Ty21a). Newer conjugate vaccine (TCV) used in national programs.

  ConjugateTravel

• Varicella Chickenpox Vaccine

  Live attenuated vaccine. Standalone (Varivax) or MMRV combination (ProQuad). MMRV has elevated febrile seizure risk.

  Live attenuatedRoutineInfant & child

• Yellow Fever Yellow Fever Vaccine

  Live attenuated vaccine. Single dose, lifelong protection for most. Required by IHR for certain countries.

  Live attenuatedTravel

No vaccine matches those filters. Clear filters

A platform chip appears only where this site's own vaccine registry states it; where it does not, the card says so rather than guessing. Corrections are welcome through the corrections form.